Star Lake Bioscience (600866.SH)'s controlling shareholder plans to increase its stake in the company by RMB75 million to RMB150 million.

date
22:39 13/11/2026
avatar
GMT Eight
Star Lake Bioscience (600866.SH) announced that its controlling shareholder, Guangdong Guangxin Holdings Group Co., Ltd. (hereinafter referred to as "Guangxin Group"), plans to increase its stake in the company through centralized bidding via the Shanghai Stock Exchange system within 12 months from the date of disclosure of this announcement. The planned increase amount shall be no less than RMB75 million and no more than RMB150 million (both inclusive), and the proposed increase ratio shall not exceed 2% of the company's total share capital. No stock price range is set for this increase, and the source of funds for the increase is its own funds and special loans from financial institutions for the increase.
Star Lake Bioscience (600866.SH) announced that its controlling shareholder, Guangdong Guangxin Holdings Group Co., Ltd. (hereinafter referred to as "Guangxin Group"), plans to increase its stake in the company through centralized bidding via the Shanghai Stock Exchange system within 12 months from the date of disclosure of this announcement. The planned increase amount shall be no less than RMB75 million and no more than RMB150 million (both inclusive), and the proposed increase ratio shall not exceed 2% of the company's total share capital. No stock price range is set for this increase, and the source of funds for the increase is its own funds and special loans from financial institutions for the increase.